Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06015932 · ClinicalTrials.gov registry record · NA

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

A NA study of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06015932 is a NA study of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 400 participants, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06015932, a NA study of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This clinical trial tests how well cognitive behavioral cancer stress management (CBCSM) group sessions work to decrease psychological distress in cancer patients. CBCSM teaches patients how to recognize and reduce the impacts of cancer associated stress on the biological, psychological, and social life domains.

Interventions

  • OTHER Questionnaire Administration
  • BEHAVIORAL Cognitive Behavior Therapy

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2017-12-20
Est. Completion 2029-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06015932

The ClinicalTrials.gov registry entry for NCT06015932 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (65% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT06015932 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06015932 about?

NCT06015932 is a clinical study titled "Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients". This clinical trial tests how well cognitive behavioral cancer stress management (CBCSM) group sessions work to decrease psychological distress in cancer patients. CBCSM teaches patients how to recognize and reduce the impacts of cancer associated stress on the biological, psychological, and social ...

What is the current status of trial NCT06015932?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2017-12-20. Estimated completion is 2029-12.

What conditions does trial NCT06015932 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm.

What interventions are being tested in trial NCT06015932?

The interventions under investigation include: Questionnaire Administration (OTHER), Cognitive Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06015932?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06015932 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.